MedPath

Sevoflurane

Sevoflurane USPvolatile liquid for inhalation

Approved
Approval ID

5bfc1cef-824d-4ebf-bb4d-fbc46c0abb79

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 19, 2023

Manufacturers
FDA

Lannett Company, Inc.

DUNS: 002277481

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Sevoflurane

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0527-6123
Application NumberANDA214382
Product Classification
M
Marketing Category
C73584
G
Generic Name
Sevoflurane
Product Specifications
Route of AdministrationRESPIRATORY (INHALATION)
Effective DateSeptember 19, 2023
FDA Product Classification

INGREDIENTS (1)

SevofluraneActive
Quantity: 250 mL in 250 mL
Code: 38LVP0K73A
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Sevoflurane - FDA Drug Approval Details